Current Drug Targets


Francis J. Castellino
(14643 citations)
Dean Emeritus, College of Science,
Kleiderer-Pezold Professor of Biochemistry
Director, W.M. Keck Center for Transgene Research
230 Raclin-Carmichael Hall, University of Notre Dame
Notre Dame, IN 46556

Personal Subscription
Become EABM
Become Reviewer
Call for Editor
Volume: 15 Issue: 2, February 2014

The First Approved Agent in the Glitazar’s Class: Saroglitazar

Volume:15   Issue: 2
Pp: 151-155
Ritesh Agrawal
DOI: 10.2174/13894501113149990199
Published on: 31 July, 2013

Communication Factors-Promising Targets in Osteoporosis Treatment

Volume:15   Issue: 2
Pp: 156-163
Yan Zhang, Peijun Liu, Juan Li, Kun Li, Yue Teng, Xiang Wang and Xu Li
DOI: 10.2174/13894501113149990200
Published on: 05 August, 2013

Inducible Nitric Oxide Synthase as a Possible Target in Hypertension

Volume:15   Issue: 2
Pp: 164-174
Gustavo H. Oliveira-Paula, Riccardo Lacchini and Jose E. Tanus-Santos
DOI: 10.2174/13894501113146660227
Published on: 08 October, 2013

The Medicinal Potential of Natural Products for the Development of Anti- Influenza Agents

Volume:15   Issue: 2
Pp: 175-183
Fudong Sun and Ruiqin Huang
DOI: 10.2174/13894501113146660203
Published on: 19 August, 2013

A Review on Skin Targeted Delivery of Bioactives as Ultradeformable Vesicles: Overcoming the Penetration Problem

Volume:15   Issue: 2
Pp: 184-198
Karunanidhi Priyanka and Sanjay Singh
DOI: 10.2174/1389450115666140113100338
Published on: 12 January, 2014

Pathophysiology and Pharmacologic Treatment of Venous Thromboembolism

Volume:15   Issue: 2
Pp: 199-209
Jonathan Bain, Douglas R. Oyler, Susan S. Smyth and Tracy E. Macaulay
DOI: 10.2174/13894501113146660226
Published on: 08 October, 2013

Drug Therapy of Neuropathic Pain: Current Developments and Future Perspectives

Volume:15   Issue: 2
Pp: 210-253
Arunachalam Muthuraman, Nirmal Singh, Amteshwar Singh Jaggi and Muthusamy Ramesh
DOI: 10.2174/1389210200418434501
Published on: 03 October, 2013